Haemonetics Balance Sheet
HAE / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 15 fiscal years. All figures from audited SEC 10-K filings.
Haemonetics had $2.5B in total assets and $821M in shareholders' equity as of FY2025. Total debt was $1.2B against $307M in cash, resulting in $939M net debt.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $306.8M | $178.8M | $284.5M | $259.5M | $192.3M | $137.3M | $169.4M | $180.2M | $139.6M | $115.1M | $160.7M | $192.5M | $179.1M | $228.9M | $196.7M |
| Accounts Receivable | $202.7M | $206.6M | $179.1M | $159.4M | $127.6M | $165.2M | $185.0M | $151.2M | $152.7M | $157.1M | $145.8M | $164.6M | $170.1M | $135.5M | $127.2M |
| Inventory | $365.1M | $317.2M | $259.4M | $293.0M | $322.6M | $270.3M | $194.3M | $160.8M | $176.9M | $187.0M | $211.1M | $197.7M | $183.8M | $117.2M | $84.4M |
| Current Assets | $935.0M | $768.9M | $769.7M | $756.0M | $693.5M | $603.6M | $576.1M | $521.2M | $510.0M | $488.1M | $557.7M | $623.0M | $597.0M | $527.1M | $448.8M |
| PP&E (Net) | $284.1M | $311.4M | $310.9M | $258.5M | $217.6M | $253.4M | $344.0M | $332.2M | $323.9M | $337.6M | $321.9M | $271.4M | $257.0M | $161.7M | $155.5M |
| Goodwill | $604.3M | $565.1M | $466.2M | $467.3M | $466.4M | $210.7M | $210.8M | $211.4M | $210.8M | $267.8M | $334.3M | $336.8M | $330.5M | $115.1M | $115.4M |
| Total Assets | $2.5B | $2.2B | $1.9B | $1.9B | $1.8B | $1.3B | $1.3B | $1.2B | $1.2B | $1.3B | $1.5B | $1.5B | $1.5B | $911.1M | $833.3M |
| Current Liabilities | $578.1M | $300.4M | $251.8M | $442.3M | $253.5M | $274.8M | $235.8M | $384.7M | $211.2M | $185.6M | $188.7M | $216.9M | $180.1M | $130.7M | $108.7M |
| Total Debt | $1.2B | $797.6M | $754.1M | $559.4M | $690.6M | $305.5M | $322.5M | $59.4M | $315.8M | $408.5M | $430.5M | $392.1M | $480.1M | $3.8M | $4.9M |
| Shareholders' Equity | $820.8M | $960.0M | $818.0M | $749.4M | $731.7M | $587.1M | $667.9M | $752.4M | $739.6M | $721.6M | $826.1M | $837.9M | $769.2M | $732.6M | $686.1M |